Wupeng Liao

Liao Wupeng

Appointment(s)
  • Senior Research Fellow, Department of Pharmacology
Academic Qualifications
  • PhD, National University of Singapore, Singapore
  • BS, Nankai University, China
Research Interest(s)
  • Asthma
  • COPD
  • Airway Inflammation
  • Steroid Resistance
  • Traditional Medicine
Recent Publications
  • 1. Tan WSD, Liao W, Zhou S, Mei D, Wong WSF. 2018 Jun. Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases. Current Opinion in Pharmacology. 40:9-17. doi: 10.1016/j.coph.2017.12.002.
  • 2. Tan WSD, Liao W, Zhou S, Wong WSF. 2017 Sep. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochemical Pharmacology. 139:71-81. doi: 10.1016/j.bcp.2017.03.024.
  • 3. Dong J, Liao W, Peh HY, Chan TK, Tan WSD, Li L, Yong A, Wong WSF. 2017 Apr. Ribosomal protein S3 gene silencing protects against experimental allergic asthma. British Journal of Pharmacology. 174(7):540-552. doi: 10.1111/bph.13717.
  • 4. Liao W, Hei TK, Cheng SK. 2017 Jan. Radiation-Induced Dermatitis is Mediated by IL17-Expressing γδ T Cells. Radiation Research. doi: 10.1667/RR0007CC.1.
  • 5. Liao W, Dong J, Peh HY, Tan LH, Lim KS, Li L, Wong WSF. 2017 Jan. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. Molecules. 22(1):139. doi: 10.3390/molecules22010139.